Overview
- The government-run TrumpRx.gov is live with about 43 prescription medicines and functions as a portal that routes users to manufacturer sales channels or generates pharmacy coupons rather than selling directly.
- Initial listings include high-profile GLP-1 weight-loss drugs such as Ozempic, Wegovy and Zepbound, plus select fertility, diabetes and other treatments highlighted at the White House launch.
- The administration says at least 16 major drugmakers agreed to participate under a 'most favored nation' pricing frame; the site currently shows offers tied to companies including AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer.
- Advertised examples include Ozempic and Wegovy starting as low as $199 per month and Zepbound from $299, with other cuts such as Epclusa at $2,425 from roughly $24,920, though purchases are self-pay and typically do not count toward insurance deductibles.
- Open questions persist on transparency and durability of discounts as Public Citizen pursues a FOIA lawsuit over the agreements, reporting indicates the portal relies on GoodRx pricing data, and Democrats have flagged potential conflict-of-interest concerns involving BlinkRx and Trump family ties.